N-（Substituted benzyl）-3,5-bis（benzylidene）-4-piperidones： Synthesis and Preliminary Anti-leukemia Activity （I）  

作　　者：王静 孟雯 倪振杰 薛思佳 

机构地区：[1]Department of Chemistry, College of Life and Environmental Science, Shanghai Normal University, Shanghai 200234, China

出　　处：《Chinese Journal of Chemistry》2011年第10期2109-2113,共5页中国化学（英文版）

摘　　要：A series of novel N-（substituted benzyl）-3,5-bis（benzylidene）-4-piperidones 5a--50 were synthesized with substituted benzylamines as raw materials via a series of Michael addition, Dieckmann condensation, hydrolysis decarboxylation and aldol condensation. The structures were confirmed by 1↑H NMR, IR, MS techniques and elemental analysis. Assay-based antiproliferative activity study using leukemic cell lines K562 revealed that most of the title compounds have high effectiveness in inhibiting leukemia K562 cells proliferation, among which the compounds 5g （IC50=7.81 μg·mL^-1）, 5k （IC50=6.35μg·mL^-1）, 51 （IC50=7.20 μg·mL^-1）, and 50 （IC50=5.79 μg·mL^-1） have better inhibition activities than standard 5-fluorouracil （IC50=8.56 μg·mL^-1）.A series of novel N-（substituted benzyl）-3,5-bis（benzylidene）-4-piperidones 5a--50 were synthesized with substituted benzylamines as raw materials via a series of Michael addition, Dieckmann condensation, hydrolysis decarboxylation and aldol condensation. The structures were confirmed by 1↑H NMR, IR, MS techniques and elemental analysis. Assay-based antiproliferative activity study using leukemic cell lines K562 revealed that most of the title compounds have high effectiveness in inhibiting leukemia K562 cells proliferation, among which the compounds 5g （IC50=7.81 μg·mL^-1）, 5k （IC50=6.35μg·mL^-1）, 51 （IC50=7.20 μg·mL^-1）, and 50 （IC50=5.79 μg·mL^-1） have better inhibition activities than standard 5-fluorouracil （IC50=8.56 μg·mL^-1）.

关 键 词：4-piperidone SYNTHESIS inhibition leukemia K562 cell MTT 

分 类 号：TQ655[化学工程—精细化工] Q71[生物学—分子生物学]